PREPARATION WITH
HYPOLIPIDEMIC EFFECT «SIMVAGLYZINE»
Description and properties
New preparation with hypolipidemic effect is a molecular complex of simvastatine and β-glycyrrhizic acid with molar ratio 1:(1-4).
The given complex is characterized by a reduced toxic effect due to a decreased doze of statine, with therapeutic properties being high.
Advantages
Low-toxic medication; decrease of effective medical doze; simplicity of production; low price in comparison with the analogues (2-3 times lower).
Application
Anti-hyperlipemia therapy
Patents
Patent of the Russian Federation № 2308947 "Medication with hypolipidemic effect "Simvaglizine"
Commercial offer
Licensing agreement
Practical realization
Delivery of pilot batch and technical support in testing process. Cooperation in organization of industrial production.
N.N. Vorozhtsov Novosibirsk Institute of Organic Chemistry,
Siberian Branch of the Russian Academy of Sciences
9, Acad. Lavrentiev Ave, 630090, Novosibirsk, 90, Russsia
PhD. N. F. Salakhutdinov, Head of the Department
Tel.: (383) 214-29-86; (383) 330-97-33; E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.